JOANN ST. PIERRE: Open Payments
NPI 1922173053 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,401 in 98 payments from 11 companies in 2025. Trend: 2023 $1,294 · 2024 $1,532 · 2025 $8,401
Honoraria: $5,000Food & beverage: $2,147Consulting: $675Travel & lodging: $579
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 23 | $6,279 |
| PFIZER INC. | 6 | $818 |
| ABBVIE INC. | 32 | $558 |
| Eisai Inc. | 8 | $215 |
| Novartis Pharmaceuticals Corporation | 14 | $182 |
| UCB, Inc. | 6 | $169 |
| Grifols USA, LLC | 3 | $81 |
| Lilly USA, LLC | 2 | $33 |
| ACADIA Pharmaceuticals Inc | 2 | $32 |
| CSL Behring | 1 | $18 |
Products named: Symbravo, NURTEC ODT, QULIPTA, Leqembi, BOTOX, KESIMPTA, Briviact, Gamunex-C.
Industry payments across TX — which companies pay providers there.
